Understanding the treatment preferences of people with relapsing remitting multiple sclerosis

被引:0
|
作者
Ford, H. [1 ]
Manzano, A. [2 ]
Eskyte, I. [2 ]
Pavitt, S. [2 ]
Pepper, G. [3 ]
Schmierer, K.
Chataway, J. [4 ]
Potrata, B. [5 ]
Webb, E. [2 ]
Meads, D. [2 ]
Marti, J. [6 ]
Bekker, H. [2 ]
机构
[1] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
[2] Univ Leeds, Leeds, W Yorkshire, England
[3] Shift Ms, Leeds, W Yorkshire, England
[4] UCL, London, England
[5] Gallup, London, England
[6] Imperial Coll London, London, England
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EP1746
引用
收藏
页码:919 / 920
页数:2
相关论文
共 50 条
  • [21] Natalizumab for Relapsing Remitting Multiple Sclerosis
    Pucci, Eugenio
    Giuliani, Giorgio
    Solari, Alessandra
    Simi, Silvana
    Minozzi, Silvia
    Di Pietrantonj, Carlo
    Galea, Ian
    BAHRAIN MEDICAL BULLETIN, 2011, 33 (04)
  • [22] CONTEMPORARY TREATMENT OPTIONS FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Salhofer-Polanyi, S.
    Leutmezer, F.
    DRUGS OF TODAY, 2014, 50 (05) : 365 - 383
  • [23] ORAL FINGOLIMOD FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Vosiliou, S.
    DRUGS OF TODAY, 2010, 46 (05) : 315 - 325
  • [24] Natalizumab for relapsing remitting multiple sclerosis
    Pucci, Eugenio
    Giuliani, Giorgio
    Solari, Alessandra
    Simi, Silvana
    Minozzi, Silvia
    Di Pietrantonj, Carlo
    Galea, Ian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (10):
  • [25] The Danish experience of teriflunomide treatment in relapsing remitting multiple sclerosis
    Magyari, M.
    Buron, M.
    Illes, Z.
    Sellebjerg, F.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 472 - 472
  • [26] Time-to-Treatment In The Management Of Relapsing/Remitting Multiple Sclerosis
    Pont, Lisa G.
    Semerdijan, Minass
    Burke, Therese
    Mekhael, Linda
    Vucic, Stephen
    Hughes, Vanessa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 207 - 208
  • [27] Oral laquinimod for treatment of relapsing-remitting multiple sclerosis
    Weiner, Howard L.
    LANCET NEUROLOGY, 2008, 7 (08): : 672 - 673
  • [28] Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis
    Ingwersen, Jens
    Aktas, Orhan
    Hartung, Hans-Peter
    NEUROTHERAPEUTICS, 2016, 13 (01) : 47 - 57
  • [29] Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis
    Johnson, Kenneth P.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (04) : 371 - 384
  • [30] An evaluation of dimethyl fumarate for the treatment of relapsing remitting multiple sclerosis
    Valencia-Sanchez, Cristina
    Carter, Jonathan L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (12) : 1399 - 1405